Oral immunotherapy for the treatment of food allergy

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 8, 2014, Pages 2295-2302

  Bégin, Philippe ^a,b   Chinthrajah, R Sharon ^a   Nadeau, Kari C ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Efficacy; Food allergy; Omalizumab; Oral immunotherapy (OIT); Rush; Safety; Tolerance

Indexed keywords

FOOD ALLERGEN; OMALIZUMAB; IMMUNOLOGIC FACTOR;

CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPARATIVE EFFECTIVENESS; DESENSITIZATION; DRUG EFFICACY; FOOD ALLERGY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; ORAL IMMUNOTHERAPY; PATIENT SAFETY; QUALITY OF LIFE; REVIEW; RISK FACTOR; SUBLINGUAL IMMUNOTHERAPY; CLINICAL TRIAL (TOPIC); FOOD HYPERSENSITIVITY; IMMUNOTHERAPY; ORAL DRUG ADMINISTRATION; PROCEDURES; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; CLINICAL TRIALS AS TOPIC; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; TREATMENT OUTCOME;

EID: 84908365163     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.29233     Document Type: Review

References (65)

1. Larché M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006; 6:761-71; PMID:16998509; http://dx.doi.org/10.1038/nri1934
2. Ring J, Gutermuth J. 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). Allergy 2011; 66:713-24; PMID:21320133; http://dx.doi.org/10.1111/j.1398-9995.2010.02541.x
3. Fujita H, Soyka MB, Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy 2012; 2:2; PMID:22409879; http://dx.doi.org/10.1186/2045-7022-2-2
4. Schofield AT. A case of egg poisoning. Lancet 1908; 1:716; http://dx.doi.org/10.1016/S0140-6736(00)67313-0
5. Patriarca C, Romano A, Venuti A, Schiavino D, Di Rienzo V, Nucera E, Pellegrino S. Oral specific hyposensitization in the management of patients allergic to food. Allergol Immunopathol (Madr) 1984; 12:275-81; PMID:6507224
6. Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99:744-51; PMID:9215240; http://dx.doi.org/10.1016/S0091-6749(97)80006-1
7. Patriarca G, Nucera E, Roncallo C, Pollastrini E, Bartolozzi F, De Pasquale T, Buonomo A, Gasbarrini G, Di Campli C, Schiavino D. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 2003; 17:459-65; PMID:12562461; http://dx.doi.org/10.1046/j.1365-2036.2003.01468.x
8. Staden U, Rolinck-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 2007; 62:1261-9; PMID:17919140; http://dx.doi.org/10.1111/j.1398-9995.2007.01501.x
9. Skripak JM, Nash SD, Rowley H, Brereton NH, Oh S, Hamilton RG, Matsui EC, Burks AW, Wood RA. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2008; 122:1154-60; PMID:18951617; http://dx.doi.org/10.1016/j.jaci.2008.09.030
10. Zapatero L, Alonso E, Fuentes V, Martínez MI. Oral desensitization in children with cow's milk allergy. J Investig Allergol Clin Immunol 2008; 18:389-96; PMID:18973104
11. Longo G, Barbi E, Berti I, Meneghetti R, Pittalis A, Ronfani L, Ventura A. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 2008; 121:343-7; PMID:18158176; http://dx.doi.org/10.1016/j.jaci.2007.10.029
12. Narisety SD, Skripak JM, Steele P, Hamilton RG, Matsui EC, Burks AW, Wood RA. Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2009; 124:610-2; PMID:19665770; http://dx.doi.org/10.1016/j.jaci.2009.06.025
13. Pajno GB, Caminiti L, Ruggeri P, De Luca R, Vita D, La Rosa M, et al. Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, &. Immunology 2010; 105:376-81
14. Martorell A, De la Hoz B, Ibáñez MD, Bone J, Terrados MS, Michavila A, Plaza AM, Alonso E, Garde J, Nevot S, et al. Oral desensitization as a useful treatment in 2-year-old children with cow's milk allergy. Clin Exp Allergy 2011; 41:1297-304; PMID:21481024; http://dx.doi.org/10.1111/j.1365-2222.2011.03749.x
15. Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, Schroeder JT, Hamilton RG, Boden S, Steele P, Driggers S, Burks AW, Wood RA. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 2012; 129:448-55, e1-5; PMID:22130425; http://dx.doi.org/10.1016/j.jaci.2011.10.023
16. Salmivesi S, Korppi M, Mäkelä MJ, Paassilta M. Milk oral immunotherapy is effective in school-aged children. Acta Paediatr 2013; 102:172-6; PMID:22897785; http://dx.doi.org/10.1111/j.1651-2227.2012.02815.x
17. Vázquez-Ortiz M, Alvaro-Lozano M, Alsina L, Garcia-Paba MB, Piquer-Gibert M, Giner-Muñoz MT, Lozano J, Domínguez-Sánchez O, Jiménez R, Días M, et al. Safety and predictors of adverse events during oral immunotherapy for milk allergy: severity of reaction at oral challenge, specific IgE and prick test. Clin Exp Allergy 2013; 43:92-102; PMID:23278884; http://dx.doi.org/10.1111/cea.12012
18. Savilahti EM, Kuitunen M, Valori M, Rantanen V, Bardina L, Gimenez G, Mäkelä MJ, Hautaniemi S, Savilahti E, Sampson HA. Use of IgE and IgG4 epitope binding to predict the outcome of oral immunotherapy in cow's milk allergy. Pediatr Allergy Immunol 2014; 25:227-35; PMID:24393339; http://dx.doi.org/10.1111/pai.12186
19. Buchanan AD, Green TD, Jones SM, Scurlock AM, Christie L, Althage KA, Steele PH, Pons L, Helm RM, Lee LA, et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007; 119:199-205; PMID:17208602; http://dx.doi.org/10.1016/j.jaci.2006.09.016.
20. Itoh N, Itagaki Y, Kurihara K. Rush specific oral tolerance induction in school-age children with severe egg allergy: one year follow up. Allergol Int 2010; 59:43-51; PMID:19946197; http://dx.doi.org/10.2332/allergolint.09-OA-0107
21. Vickery BP, Pons L, Kulis M, Steele P, Jones SM, Burks AW. Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol 2010; 105:444-50; PMID:21130382; http://dx.doi.org/10.1016/j.anai.2010.09.030
22. García Rodríguez R, Urra JM, Feo-Brito F, Galindo PA, Borja J, Gómez E, Lara P, Guerra F. Oral rush desensitization to egg: efficacy and safety. Clin Exp Allergy 2011; 41:1289-96; PMID:21457166; http://dx.doi.org/10.1111/j.1365-2222.2011.03722.x
23. Burks AW, Jones SM, Wood RA, Fleischer DM, Sicherer SH, Lindblad RW, Stablein D, Henning AK, Vickery BP, Liu AH, et al.; Consortium of Food Allergy Research (CoFAR). Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012; 367:233-43; PMID:22808958; http://dx.doi.org/10.1056/NEJMoa1200435
24. Meglio P, Giampietro PG, Carello R, Gabriele I, Avitabile S, Galli E. Oral food desensitization in children with IgE-mediated hen's egg allergy: a new protocol with raw hen's egg. Pediatr Allergy Immunol 2013; 24:75-83; PMID:22882430; http://dx.doi.org/10.1111/j.1399-3038.2012.01341.x
25. Dello Iacono I, Tripodi S, Calvani M, Panetta V, Verga MC, Miceli Sopo S. Specific oral tolerance induction with raw hen's egg in children with very severe egg allergy: a randomized controlled trial. Pediatr Allergy Immunol 2013; 24:66-74; PMID:22957889; http://dx.doi.org/10.1111/j.1399-3038.2012.01349.x
26. Vazquez-Ortiz M, Alvaro M, Piquer M, Dominguez O, Machinena A, Martín-Mateos MA, Plaza AM. Baseline specific IgE levels are useful to predict safety of oral immunotherapy in egg-allergic children. Clin Exp Allergy 2014; 44:130-41; PMID:24355019; http://dx.doi.org/10.1111/cea.12233
27. Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW. Successful oral tolerance induction in severe peanut allergy. Allergy 2009; 64:1218-20; PMID:19226304; http://dx.doi.org/10.1111/j.1398-9995.2009.01982.x
28. Jones SM, Pons L, Roberts JL, Scurlock AM, Perry TT, Kulis M, Shreffler WG, Steele P, Henry KA, Adair M, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009; 124:292-300, e1-97; PMID:19577283; http://dx.doi.org/10.1016/j.jaci.2009.05.022
29. Blumchen K, Ulbricht H, Staden U, Dobberstein K, Beschorner J, de Oliveira LC, Shreffler WG, Sampson HA, Niggemann B, Wahn U, et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010; 126:83, e1; PMID:20542324; http://dx.doi.org/10.1016/j.jaci.2010.04.030
30. Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, Hiegel A, Kamilaris J, Carlisle S, Yue X, et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011; 127:654-60; PMID:21377034; http://dx.doi.org/10.1016/j.jaci.2010.12.1111
31. Bégin P, Winterroth LC, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A, Hoyte E, O'Riordan G, et al. Safety and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy Asthma Clin Immunol 2014; 10:1; PMID:24428859; http://dx.doi.org/10.1186/1710-1492-10-1
32. Wasserman RL, Factor JM, Baker JW, Mansfield LE, Katz Y, Hague AR, Paul MM, Sugerman RW, Lee JO, Lester MR, et al. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions. J Allergy Clin Immunol Pract 2014; 2:91-6; PMID:24565775; http://dx.doi.org/10.1016/j.jaip.2013.10.001
33. Anagnostou K, Islam S, King Y, Foley L, Pasea L, Bond S, Palmer C, Deighton J, Ewan P, Clark A. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet 2014; 383:1297-304; PMID:24485709; http://dx.doi.org/10.1016/S0140-6736(13)62301-6
34. Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol 2014; 133:468-75; PMID:24361082; http://dx.doi.org/10.1016/j.jaci.2013.11.007
35. Syed A, Garcia MA, Lyu SC, Bucayu R, Kohli A, Ishida S, Berglund JP, Tsai M, Maecker H, O'Riordan G, et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol 2014; 133:500-10; PMID:24636474; http://dx.doi.org/10.1016/j.jaci.2013.12.1037
36. Hofmann AM, Scurlock AM, Jones SM, Palmer KP, Lokhnygina Y, Steele PH, Kamilaris J, Burks AW. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009; 124:286-91, e1-6; PMID:19477496; http://dx.doi.org/10.1016/j.jaci.2009.03.045
37. Meglio P, Bartone E, Plantamura M, Arabito E, Giampietro PG. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. [eng.]. Allergy 2004; 59:980-7; PMID:15291907; http://dx.doi.org/10.1111/j.1398-9995.2004.00542.x
38. Yu GP, Weldon B, Neale-May S, Nadeau KC. The safety of peanut oral immunotherapy in peanut-allergic subjects in a single-center trial. Int Arch Allergy Immunol 2012; 159:179-82; PMID:22678151; http://dx.doi.org/10.1159/000336391
39. Bégin P, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A, Tavassoli M, Hoyte E, O'Riordan G, et al. Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab. Allergy Asthma Clin Immunol 2014; 10:7; PMID:24576338
40. Takahashi M, Taniuchi S, Soejima K, Sudo K, Hatano Y, Kaneko K. New efficacy of LTRAs (montelukast sodium): it possibly prevents food-induced abdominal symptoms during oral immunotherapy. Allergy Asthma Clin Immunol 2014; 10:3; PMID:24438769; http://dx.doi.org/10.1186/1710-1492-10-3
41. Hague AR, Wasserman RL, Silvers SK. RW S. Single Practice Five-Year Experience Treating Food Allergy With Oral Immunotherapy: Efficacy and Epinephrine Treated Reactions. J Allergy Clin Immunol 2014; 133:AB104; http://dx.doi.org/10.1016/j.jaci.2013.12.388
42. Neuman-Sunshine DL, Eckman JA, Keet CA, Matsui EC, Peng RD, Lenehan PJ, Wood RA. The natural history of persistent peanut allergy. Ann Allergy Asthma Immunol 2012; 108:326, e3; PMID:22541403; http://dx.doi.org/10.1016/j.anai.2011.11.010
43. Wood RA, Sampson HA. Oral immunotherapy for the treatment of peanut allergy: is it ready for prime time? J Allergy Clin Immunol Pract 2014; 2:97-8; PMID:24565776; http://dx.doi.org/10.1016/j.jaip.2013.11.010
44. Primeau MN, Kagan R, Joseph L, Lim H, Dufresne C, Duffy C, Prhcal D, Clarke A. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy 2000; 30:1135-43; PMID:10931121; http://dx.doi.org/10.1046/j.1365-2222.2000.00889.x
45. Factor JM, Mendelson L, Lee J, Nouman G, Lester MR. Effect of oral immunotherapy to peanut on food-specific quality of life. Ann Allergy Asthma Immunol 2012; 109:348, e2; PMID:23062391; http://dx.doi.org/10.1016/j.anai.2012.08.015
46. Carraro S, Frigo AC, Perin M, Stefani S, Cardarelli C, Bozzetto S, Baraldi E, Zanconato S. Impact of oral immunotherapy on quality of life in children with cow milk allergy: a pilot study. Int J Immunopathol Pharmacol 2012; 25:793-8; PMID:23058033
47. Anagnostou K, Islam S, King Y, Foley L, Pasea L, Bond S, Palmer C, Deighton J, Ewan P, Clark A. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet 2014; 383:1297-304; PMID:24485709; http://dx.doi.org/10.1016/S0140-6736(13)62301-6
48. Staden U, Blumchen K, Blankenstein N, Dannenberg N, Ulbricht H, Dobberstein K, Ziegert M, Niggemann B, Wahn U, Beyer K. Rush oral immunotherapy in children with persistent cow's milk allergy. J Allergy Clin Immunol 2008; 122:418-9; PMID:18602681; http://dx.doi.org/10.1016/j.jaci.2008.06.002
49. Barbi E, Longo G, Berti I, Neri E, Saccari A, Rubert L, Matarazzo L, Montico M, Ventura A. Adverse effects during specific oral tolerance induction: in-hospital "rush" phase. Eur Ann Allergy Clin Immunol 2012; 44:18-25; PMID:22519128
50. Gupta RS, Springston EE, Warrier MR, Smith B, Kumar R, Pongracic J, Holl JL. The prevalence, severity, and distribution of childhood food allergy in the United States. [eng.]. Pediatrics 2011; 128:e9-17; PMID:21690110; http://dx.doi.org/10.1542/peds.2011-0204
51. Wang J, Visness CM, Sampson HA. Food allergen sensitization in inner-city children with asthma. [eng.]. J Allergy Clin Immunol 2005; 115:1076-80; PMID:15867869; http://dx.doi.org/10.1016/j.jaci.2005.02.014
52. Wang J. Management of the patient with multiple food allergies. [eng.]. Curr Allergy Asthma Rep 2010; 10:271-7; PMID:20431971; http://dx.doi.org/10.1007/s11882-010-0116-0
53. Sicherer SH, Noone SA, Muñoz-Furlong A. The impact of childhood food allergy on quality of life. [eng.]. Ann Allergy Asthma Immunol 2001; 87:461-4; PMID:11770692; http://dx.doi.org/10.1016/S1081-1206(10)62258-2
54. Christie L, Hine RJ, Parker JG, Burks W. Food allergies in children affect nutrient intake and growth. [eng.]. J Am Diet Assoc 2002; 102:1648-51; PMID:12449289; http://dx.doi.org/10.1016/S0002-8223(02)90351-2
55. Savage JH, Matsui EC, Skripak JM, Wood RA. The natural history of egg allergy. [eng.]. J Allergy Clin Immunol 2007; 120:1413-7; PMID:18073126; http://dx.doi.org/10.1016/j.jaci.2007.09.040
56. Savage JH, Courneya JP, Sterba PM, Macglashan DW, Saini SS, Wood RA. Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy. J Allergy Clin Immunol 2012; 130:1123, e2; PMID:22800401; http://dx.doi.org/10.1016/j.jaci.2012.05.039
57. Gernez Y, Tirouvanziam R, Yu G, Ghosn EE, Reshamwala N, Nguyen T, Tsai M, Galli SJ, Herzenberg LA, Herzenberg LA, et al. Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy. Int Arch Allergy Immunol 2011; 154:318-27; PMID:20975283; http://dx.doi.org/10.1159/000321824
58. Yu GP, Tuano KS, Hamilton RG, Nadeau KC. Omalizumab in peanut-allergic patients reduces free IgE anti-peanut and skin prick test to peanut. J Allergy Clin Immunol 2010; 125(Supp 1):AB22; http://dx.doi.org/10.1016/j.jaci.2009.12.119
59. Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH, Townley RG, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, et al.; Immune Tolerance Network Group. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for rag-weed-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2006; 117:134-40; PMID:16387596; http://dx.doi.org/10.1016/j.jaci.2005.09.036
60. Nadeau KC, Schneider LC, Hoyte L, Borras I, Umetsu DT. Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy. J Allergy Clin Immunol 2011; 127:1622-4; PMID:21546071; http://dx.doi.org/10.1016/j.jaci.2011.04.009
61. Klunker S, Saggar LR, Seyfert-Margolis V, Asare AL, Casale TB, Durham SR, Francis JN; Immune Tolerance Network Group. Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding. J Allergy Clin Immunol 2007; 120:688-95; PMID:17631952; http://dx.doi.org/10.1016/j.jaci.2007.05.034
62. Parks KW, Casale TB. Anti-immunoglobulin E monoclonal antibody administered with immunotherapy. Allergy Asthma Proc 2006; 27(Suppl 1):S33-6; PMID:16722330
63. Nadeau KC, Kohli A, Iyengar S, DeKruyff RH, Umetsu DT. Oral immunotherapy and anti-IgE anti-body-adjunctive treatment for food allergy. [eng.]. Immunol Allergy Clin North Am 2012; 32:111-33; PMID:22244236; http://dx.doi.org/10.1016/j.iac.2011.11.004
64. Khoriaty E, Umetsu DT. Oral immunotherapy for food allergy: towards a new horizon. Allergy Asthma Immunol Res 2013; 5:3-15; PMID:23277873; http://dx.doi.org/10.4168/aair.2013.5.1.3
65. Schneider LC, Rachid R, LeBovidge J, Blood E, Mittal M, Umetsu DT. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients. J Allergy Clin Immunol 2013; 132:1368-74; PMID:24176117; http://dx.doi.org/10.1016/j.jaci.2013.09.046